Botanical species · safety record

Lilium lancifolium

The EFSA Compendium of Botanicals holds 11 constituent measurements and 2 adverse-effect records for Lilium lancifolium. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Lilium lancifolium Thunb.

11Constituent measurements
2Safety records
6Cited sources
49Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 49 licensed products naming Lilium lancifolium as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Bulb
  • Flower
  • Flowering plant
  • Herb(s)
  • Leaf
  • Lilium lancifolium - Bulb
  • Plants without bulbs
  • Scale leaves

What the records describe

Constituents measured

  • Medioresinol2
  • P-coumaric acid2
  • Pinoresinol2
  • Syringaresinol2
  • Berberine1
  • Dioscin1
  • Secoisolarisiresinol1

Plant parts

  • Bulb11
  • clove11
  • Flower1
  • Leaves1

Preparations

  • Solvent extraction11

Effect types

  • Digestive1
  • Nephrotoxicity1

Target tissues

  • Digestive1
  • Urogenital: kidneys1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
P-coumaric acidBulb / cloveSolvent extraction≥ 0.25 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
P-coumaric acidBulb / cloveSolvent extraction≤ 1.93 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
BerberineLeavesSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
DioscinBulb / cloveSolvent extractionHPLC-ELSDNo resolvable identifier
MedioresinolBulb / cloveSolvent extraction≤ 10 Microgram/100 gramGC-MSNo resolvable identifier
MedioresinolBulb / cloveSolvent extraction≥ 2 Microgram/100 gramGC-MSNo resolvable identifier
PinoresinolBulb / cloveSolvent extraction≥ 58 Microgram/100 gramGC-MSNo resolvable identifier
PinoresinolBulb / cloveSolvent extraction≤ 191 Microgram/100 gramGC-MSNo resolvable identifier
SecoisolarisiresinolBulb / cloveSolvent extraction1 Microgram/100 gramGC-MSNo resolvable identifier
SyringaresinolBulb / cloveSolvent extraction≥ 40 Microgram/100 gramGC-MSNo resolvable identifier
SyringaresinolBulb / cloveSolvent extraction≤ 415 Microgram/100 gramGC-MSNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
NephrotoxicityUrogenital: kidneysFlowerCat (as animal)Case reportResolve DOI
DigestiveDigestiveBulb / cloveIn vitroNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Penalvo, Jose L., Adlercreutz, Herman., Uehara, Mariko., Ristimaki, Anna., Watanabe, Shaw. Lignan Content of Selected Foods from Japan. Journal of agricultural and food chemistry, 2008, p. 401-409.
  2. Asao, Toshio., Horiguchi, Miwa., Terada, Chikako., Takahashi, Kyoko. Purification and Characterization of a Trypsin Inhibitor from Lily Bulb (Lilium lancifolium) . Journal of the japanese society for food science and technology-nippon shokuhin kagaku kogaku kaishi, 1998, vol. 45, no. 11, p. 663-670.
  3. Berg, Rebecca I. M., Francey, Thierry., Segev, Gilad. Resolution of acute kidney injury in a cat after lily (Lilium lancifiolium) intoxication. JOURNAL OF VETERINARY INTERNAL MEDICINE, 2007, vol. 21, no. 4, p. 857-859. DOI
  4. Hu, Wen-yan., Duan, Jin-ao., Qian, Da-wei., Wang, Da-wei. Studies on chemical constituents in fresh fleshy scaleleaf of Lilium lancifolium . . Zhongguo zhong yao za zhi = zhongguo zhongyao zazhi = china journal of chinese materia medica, 2007, vol. 32, no. 16, p. 1656-9.
  5. Huang, Jiang-jian., Gao, Ying., Li, Wei-ming., Ye, Xue-lan. Quantitative determination of dioscin in Bulbus Lilii by HPLC- ELSD. Zhongguo shiyan fangjixue zazhi, 2011, p. 110-112.
  6. bagtaeyeong., seogyeongsun., coeseonggyu., Yun, KyeongWon. Chemical Constituents of Bulb of Lilium lancifolium Thunberg and Lilium tsingtauense Gilg . Korean journal of plant reources., 2014, vol. 27, no. 2, p. 125-132. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue